Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection

Area of Science:

• Immunology
• Parasitology
• Vaccinology

Background:

• Plasmodium parasites, the causative agents of malaria, produce macrophage migration inhibitory factor (PMIF) that influences host inflammatory responses.
• Understanding PMIF's role is crucial for developing effective malaria control strategies.

Purpose of the Study:

• To investigate the impact of PMIF immunoneutralization on host immune responses and malaria parasite control.
• To evaluate a novel RNA replicon-based vaccine targeting PMIF.

Main Methods:

• Development and application of an RNA replicon-based vaccine targeting PMIF.
• Assessment of Plasmodium infection control in liver and blood stages.
• Analysis of host immune responses, including T cell differentiation, antibody titers, and inflammatory markers.

Main Results:

• Vaccination against PMIF led to delayed blood-stage patency and reduced Th1-associated inflammatory markers (TNF-α, IL-12, IFN-γ).
• Enhanced T follicular helper (Tfh) cell and germinal center responses, increased anti-Plasmodium antibody titers, and improved memory CD4 T and liver-resident CD8 T cell differentiation were observed.
• Complete protection from re-infection was achieved and could be transferred via T cells from immunized hosts.

Conclusions:

• PMIF immunoneutralization is a promising strategy for enhancing immunity against Plasmodium infections.
• Targeting parasite MIF orthologs may offer a broader approach for controlling infections caused by various parasite genera.